Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 2, 2008, Pages 230-239

  Khairallah, Ramzi J ^a,e   Khairallah, Maya ^a   Gélinas, Roselle ^a   Bouchard, Bertrand ^a   Young, Martin E ^c   Allen, Bruce G ^a   Lopaschuk, Gary D ^d   Deschepper, Christian F ^b,e   Des Rosiers, Christine ^a,e  

^a MONTREAL HEART INSTITUTE   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Energy metabolism; Guanylate cyclase; Hormone sensitive lipase; Isotopes; Perfusion

Indexed keywords

ACETYL COENZYME A; ACETYL COENZYME A CARBOXYLASE; CARBON 13; CYCLIC GMP; FATTY ACID; GUANYLATE CYCLASE; HORMONE SENSITIVE LIPASE; MALONYL COENZYME A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLEIC ACID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EX VIVO STUDY; FATTY ACID OXIDATION; GLYCOLYSIS; HEART MUSCLE CELL; HEART PERFUSION; LIPID HYDROLYSIS; LIPID STORAGE; LIPOLYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRIACYLGLYCEROL BLOOD LEVEL;

ACETYL COENZYME A; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CYCLIC GMP; FATTY ACIDS; GLYCOLYSIS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCYTES, CARDIAC; OLEIC ACID; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

MUS;

EID: 48849089048     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.05.012     Document Type: Article

References (72)

1. Stanley W.C., Recchia F.A., and Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85 3 (Jul 2005) 1093-1129
2. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 356 11 (Mar 15 2007) 1140-1151
3. Sharma S., Adrogue J.V., Golfman L., Uray I., Lemm J., Youker K., et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18 14 (Nov 2004) 1692-1700
4. Borradaile N.M., and Schaffer J.E. Lipotoxicity in the heart. Curr Hypertens Rep 7 6 (Dec 2005) 412-417
5. Dyck J.R., and Lopaschuk G.D. AMPK alterations in cardiac physiology and pathology: enemy or ally?. J Physiol 574 Pt 1 (Jul 1 2006) 95-112
6. O'Neill B.T., and Abel E.D. Akt1 in the cardiovascular system: friend or foe?. J Clin Invest 115 8 (Aug 2005) 2059-2064
7. DeBosch B., Sambandam N., Weinheimer C., Courtois M., and Muslin A.J. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 281 43 (Oct 27 2006) 32841-32851
8. Costa A.D., Garlid K.D., West I.C., Lincoln T.M., Downey J.M., Cohen M.V., et al. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97 4 (Aug 19 2005) 329-336
9. Takimoto E., Champion H.C., Li M., Belardi D., Ren S., Rodriguez E.R., et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11 2 (Feb 2005) 214-222
10. Zahabi A., Picard S., Fortin N., Reudelhuber T.L., and Deschepper C.F. Expression of constitutively active guanylate cyclase in cardiomyocytes inhibits the hypertrophic effects of isoproterenol and aortic constriction on mouse hearts. J Biol Chem 278 48 (Nov 28 2003) 47694-47699
11. Khairallah M., Khairallah R.J., Young M.E., Allen B.G., Gillis M.A., Danialou G., et al. Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency. Proc Natl Acad Sci U S A 105 19 (May 13 2008) 7028-7033
12. Recchia F.A., McConnell P.I., Loke K.E., Xu X., Ochoa M., and Hintze T.H. Nitric oxide controls cardiac substrate utilization in the conscious dog. Cardiovasc Res 44 2 (Nov 1999) 325-332
13. Recchia F.A., Osorio J.C., Chandler M.P., Xu X., Panchal A.R., Lopaschuk G.D., et al. Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs. Am J Physiol Endocrinol Metab 282 1 (Jan 2002) E197-E206
14. Depre C., Vanoverschelde J.L., Goudemant J.F., Mottet I., and Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 92 7 (Oct 1 1995) 1911-1918
15. Depre C., Gaussin V., Ponchaut S., Fischer Y., Vanoverschelde J.L., and Hue L. Inhibition of myocardial glucose uptake by cGMP. Am J Physiol 274 5 Pt 2 (May 1998) H1443-H1449
16. Sengenes C., Bouloumie A., Hauner H., Berlan M., Busse R., Lafontan M., et al. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 278 49 (Dec 5 2003) 48617-48626
17. Fischmeister R., Castro L.R., bi-Gerges A., Rochais F., Jurevicius J., Leroy J., et al. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res 99 8 (Oct 13 2006) 816-828
18. Tada H., Thompson C.I., Recchia F.A., Loke K.E., Ochoa M., Smith C.J., et al. Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart. Circ Res 86 3 (Feb 18 2000) 270-274
19. Li J., Hu X., Selvakumar P., Russell III R.R., Cushman S.W., Holman G.D., et al. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol Endocrinol Metab 287 5 (Nov 2004) E834-E841
20. Khairallah M., Labarthe F., Bouchard B., Danialou G., Petrof B.J., and Des Rosiers C. Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons. Am J Physiol Heart Circ Physiol 286 4 (Apr 2004) H1461-H1470
21. Khairallah M., Khairallah R., Young M.E., Dyck J.R., Petrof B.J., and Des Rosiers C. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J Mol Cell Cardiol (May 24 2007)
22. Labarthe F., Khairallah M., Bouchard B., Stanley W.C., and Des Rosiers C. Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid. Am J Physiol Heart Circ Physiol 288 3 (Mar 2005) H1425-H1436
23. Vincent G., Bouchard B., Khairallah M., and Des Rosiers C. Differential modulation of citrate synthesis and release by fatty acids in perfused working rat hearts. Am J Physiol Heart Circ Physiol 286 1 (Jan 2004) H257-H266
24. Durgan D.J., Trexler N.A., Egbejimi O., McElfresh T.A., Suk H.Y., Petterson L.E., et al. The circadian clock within the cardiomyocyte is essential for responsiveness of the heart to fatty acids. J Biol Chem 281 34 (Aug 25 2006) 24254-24269
25. Young M.E., Razeghi P., Cedars A.M., Guthrie P.H., and Taegtmeyer H. Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res 89 12 (Dec 7 2001) 1199-1208
26. Boivin B., Villeneuve L.R., Farhat N., Chevalier D., and Allen B.G. Sub-cellular distribution of endothelin signaling pathway components in ventricular myocytes and heart: lack of preformed caveolar signalosomes. J Mol Cell Cardiol 38 4 (Apr 2005) 665-676
27. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 1 (May 1957) 497-509
28. Ametaj B.N., Bobe G., Lu Y., Young J.W., and Beitz D.C. Effect of sample preparation, length of time, and sample size on quantification of total lipids from bovine liver. J Agric Food Chem 51 8 (Apr 9 2003) 2105-2110
29. Roduit R., Masiello P., Wang S.P., Li H., Mitchell G.A., and Prentki M. A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: a study in hormone-sensitive lipase-deficient mice. Diabetes 50 9 (Sep 2001) 1970-1975
30. Ruiz J., Antequera T., Andres A.I., Petron M., and Muriel E. Improvement of a solid phase extraction method for analysis of lipid fractions in muscle foods. Analytica Chimica Acta 520 1-2 (Aug 23 2004) 201-205
31. Lepage G., Levy E., Ronco N., Smith L., Galeano N., and Roy C.C. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J Lipid Res 30 10 (Oct 1989) 1483-1490
32. Chan A.Y., Soltys C.L., Young M.E., Proud C.G., and Dyck J.R. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J Biol Chem 279 31 (2004 Jul 30) 32771-32779
33. Vavvas D., Apazidis A., Saha A.K., Gamble J., Patel A., Kemp B.E., et al. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 272 20 (May 16 1997) 13255-13261
34. Goodwin G.W., and Taegtmeyer H. Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. Am J Physiol 277 4 Pt 1 (Oct 1999) E772-E777
35. Lei B., Lionetti V., Young M.E., Chandler M.P., d'Agostino C., Kang E., et al. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. J Mol Cell Cardiol 36 4 (Apr 2004) 567-576
36. Dyck J.R., Hopkins T.A., Bonnet S., Michelakis E.D., Young M.E., Watanabe M., et al. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation 114 16 (Oct 17 2006) 1721-1728
37. Durgan D.J., Smith J.K., Hotze M.A., Egbejimi O., Cuthbert K.D., Zaha V.G., et al. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. Am J Physiol Heart Circ Physiol 290 6 (Jun 2006) H2480-H2497
38. Kerbey A.L., Randle P.J., Cooper R.H., Whitehouse S., Pask H.T., and Denton R.M. Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A and reduced and oxidized nicotinamide-adenine dinucleotide. Biochem J 154 2 (Feb 15 1976) 327-348
39. Small C.A., Garton A.J., and Yeaman S.J. The presence and role of hormone-sensitive lipase in heart muscle. Biochem J 258 1 (Feb 15 1989) 67-72
40. Schweiger M., Schreiber R., Haemmerle G., Lass A., Fledelius C., Jacobsen P., et al. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 281 52 (Dec 29 2006) 40236-40241
41. Holm C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 31 Pt 6 (Dec 2003) 1120-1124
42. Suzuki J., Shen W.J., Nelson B.D., Patel S., Veerkamp J.H., Selwood S.P., et al. Absence of cardiac lipid accumulation in transgenic mice with heart-specific HSL overexpression. Am J Physiol Endocrinol Metab 281 4 (Oct 2001) E857-E866
43. Calderone A., Thaik C.M., Takahashi N., Chang D.L., and Colucci W.S. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 101 4 (Feb 15 1998) 812-818
44. Cuthbert K.D., and Dyck J.R. Malonyl-CoA decarboxylase is a major regulator of myocardial fatty acid oxidation. Curr Hypertens Rep 7 6 (Dec 2005) 407-411
45. Garton A.J., Campbell D.G., Carling D., Hardie D.G., Colbran R.J., and Yeaman S.J. Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. Eur J Biochem 179 1 (Jan 15 1989) 249-254
46. Yeaman S.J. Hormone-sensitive lipase-new roles for an old enzyme. Biochem J 379 Pt 1 (Apr 1 2004) 11-22
47. Das A., Smolenski A., Lohmann S.M., and Kukreja R.C. Cyclic GMP-dependent protein kinase Ialpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte. J Biol Chem 281 50 (Dec 15 2006) 38644-38652
48. Parenti A., Morbidelli L., Cui X.L., Douglas J.G., Hood J.D., Granger H.J., et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 273 7 (Feb 13 1998) 4220-4226
49. Silberbach M., Gorenc T., Hershberger R.E., Stork P.J., Steyger P.S., and Roberts Jr. C.T. Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J Biol Chem 274 35 (Aug 27 1999) 24858-24864
50. Coleman R.A., and Lee D.P. Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res 43 2 (Mar 2004) 134-176
51. Muoio D.M., Seefeld K., Witters L.A., and Coleman R.A. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338 Pt 3 (Mar 15 1999) 783-791
52. Haemmerle G., Lass A., Zimmermann R., Gorkiewicz G., Meyer C., Rozman J., et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312 5774 (May 5 2006) 734-737
53. Listenberger L.L., Han X., Lewis S.E., Cases S., Farese Jr. R.V., Ory D.S., et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100 6 (Mar 18 2003) 3077-3082
54. Dimmeler S., Lottspeich F., and Brune B. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 267 24 (Aug 25 1992) 16771-16774
55. Tsuura Y., Ishida H., Shinomura T., Nishimura M., and Seino Y. Endogenous nitric oxide inhibits glucose-induced insulin secretion by suppression of phosphofructokinase activity in pancreatic islets. Biochem Biophys Res Commun 252 1 (Nov 9 1998) 34-38
56. Allard M.F., Wambolt R.B., Longnus S.L., Grist M., Lydell C.P., Parsons H.L., et al. Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. Am J Physiol Endocrinol Metab 279 3 (Sep 2000) E487-E493
57. Nascimben L., Ingwall J.S., Lorell B.H., Pinz I., Schultz V., Tornheim K., et al. Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension 44 5 (Nov 2004) 662-667
58. Lydell C.P., Chan A., Wambolt R.B., Sambandam N., Parsons H., Bondy G.P., et al. Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts. Cardiovasc Res 53 4 (Mar 2002) 841-851
59. Depre C., Shipley G.L., Chen W., Han Q., Doenst T., Moore M.L., et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 4 11 (Nov 1998) 1269-1275
60. Bueno O.F., Wilkins B.J., Tymitz K.M., Glascock B.J., Kimball T.F., Lorenz J.N., et al. Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice. Proc Natl Acad Sci U S A 99 7 (Apr 2 2002) 4586-4591
61. Antos C.L., McKinsey T.A., Frey N., Kutschke W., McAnally J., Shelton J.M., et al. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 99 2 (Jan 22 2002) 907-912
62. Marshall T., Williams J., and Williams K.M. Electrophoresis of human serum proteins following acute myocardial infarction. Biochem Soc Trans 22 3 (Aug 1994) 312S
63. Abdallah Y., Gkatzoflia A., Pieper H., Zoga E., Walther S., Kasseckert S., et al. Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 66 1 (Apr 1 2005) 123-131
64. Monastyrskaya E., Folarin N., Malyshev I., Green C., and Andreeva L. Application of the nitric oxide donor SNAP to cardiomyocytes in culture provides protection against oxidative stress. Nitric Oxide 7 2 (Sep 2002) 127-131
65. Weiss J.N., and Lamp S.T. Cardiac ATP-sensitive K+ channels. Evidence for preferential regulation by glycolysis. J Gen Physiol 94 5 (Nov 1989) 911-935
66. Aasum E., Lathrop D.A., Henden T., Sundset R., and Larsen T.S. The role of glycolysis in myocardial calcium control. J Mol Cell Cardiol 30 9 (Sep 1998) 1703-1712
67. Xu K.Y., Zweier J.L., and Becker L.C. Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport. Circ Res 77 1 (Jul 1995) 88-97
68. Glitsch H.G., and Tappe A. The Na+/K+ pump of cardiac Purkinje cells is preferentially fuelled by glycolytic ATP production. Pflugers Arch 422 4 (Jan 1993) 380-385
69. Paul R.J., Hardin C.D., Raeymaekers L., Wuytack F., and Casteels R. Preferential support of Ca2+ uptake in smooth muscle plasma membrane vesicles by an endogenous glycolytic cascade. FASEB J 3 11 (Sep 1989) 2298-2301
70. Zhou Y.T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97 4 (Feb 15 2000) 1784-1789
71. Finck B.N., Lehman J.J., Leone T.C., Welch M.J., Bennett M.J., Kovacs A., et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 109 1 (Jan 2002) 121-130
72. Unger R.H., and Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 24 Suppl 4 (Nov 2000) S28-S32